VRSN
58
2
AIV
74
2
SIG
50
-5
MOS
43
-5
MCHP
43
-11
WDC
63
13
GME
70
2
COP
47
2
EXPD
48
-5
DOV
69
2
CTSH
60
3
MO
65
5
AVGO
27
2
BA
56
-2
WMT
79
3
CME
64
5
NWSA
63
-4
HCP
62
-8
MPC
44
3
TSCO
48
-3
VRSN
58
2
AIV
74
2
SIG
50
-5
MOS
43
-5
MCHP
43
-11
WDC
63
13
GME
70
2
COP
47
2
EXPD
48
-5
DOV
69
2
CTSH
60
3
MO
65
5
AVGO
27
2
BA
56
-2
WMT
79
3
CME
64
5
NWSA
63
-4
HCP
62
-8
MPC
44
3
TSCO
48
-3
Financhill
Back

Prudential Financial Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
65

PRU
Prudential Financial

Last Price:
129.89
Seasonality Move:
4.16%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
136.50
Seasonality Move:
14.88%
Buy
65
Prudential Financial (PRU) is a Buy

Is Prudential Financial a Buy, Sell or Hold?

  • The current Prudential Financial [PRU] share price is $129.11. The Score for PRU is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • PRU is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PRU Stock Price Chart

What is Prudential Financial's stock price today?

  • The Prudential Financial share price today is $129.11
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRU is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

PRU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.3 Buy
Relative Strength Index (14 RSI): 59.82 Buy
Chaikin Money Flow: 974695 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (122.69 - 127.49) Buy
Bollinger Bands (100): (115.24 - 126.12) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

PRU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 127.03 Buy
20-day SMA: 125.12 Buy
50-day SMA: 123.54 Buy
200-day SMA: 117.32 Buy
8-day EMA: 127.18 Buy
20-day EMA: 125.8 Buy
50-day EMA: 123.61 Buy
200-day EMA: 116.6 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

Prudential Financial Earnings Growth & PRU Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.73 per share, and an increase next year of $1.33 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

Prudential Financial Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):